KR20020087591A - Preparation and its production method for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish - Google Patents
Preparation and its production method for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish Download PDFInfo
- Publication number
- KR20020087591A KR20020087591A KR1020010026279A KR20010026279A KR20020087591A KR 20020087591 A KR20020087591 A KR 20020087591A KR 1020010026279 A KR1020010026279 A KR 1020010026279A KR 20010026279 A KR20010026279 A KR 20010026279A KR 20020087591 A KR20020087591 A KR 20020087591A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- fish
- probiotics
- japonicus
- paecilomyces
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 19
- 230000012010 growth Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 230000002434 immunopotentiative effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 239000006041 probiotic Substances 0.000 claims abstract description 16
- 235000018291 probiotics Nutrition 0.000 claims abstract description 16
- 241000607626 Vibrio cholerae Species 0.000 claims abstract description 12
- 230000005965 immune activity Effects 0.000 claims abstract description 5
- 241000589540 Pseudomonas fluorescens Species 0.000 claims abstract description 3
- 229940118696 vibrio cholerae Drugs 0.000 claims abstract description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 8
- 235000019786 weight gain Nutrition 0.000 claims description 6
- 230000004584 weight gain Effects 0.000 claims description 6
- 239000003674 animal food additive Substances 0.000 claims description 4
- 238000009360 aquaculture Methods 0.000 claims description 4
- 244000144974 aquaculture Species 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 239000013587 production medium Substances 0.000 claims description 2
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 229920002472 Starch Polymers 0.000 abstract description 3
- 239000008107 starch Substances 0.000 abstract description 3
- 235000019698 starch Nutrition 0.000 abstract description 3
- 241000607471 Edwardsiella tarda Species 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 230000035755 proliferation Effects 0.000 abstract description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- 239000007836 KH2PO4 Substances 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 108010073771 Soybean Proteins Proteins 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 abstract 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 abstract 1
- 235000019797 dipotassium phosphate Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 abstract 1
- 235000019796 monopotassium phosphate Nutrition 0.000 abstract 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 abstract 1
- 235000019710 soybean protein Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 16
- 241000190633 Cordyceps Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 241000269908 Platichthys flesus Species 0.000 description 8
- 241000589516 Pseudomonas Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 210000001539 phagocyte Anatomy 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- 230000000529 probiotic effect Effects 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 241000607473 Edwardsiella <enterobacteria> Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000269978 Pleuronectiformes Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 229920000392 Zymosan Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 description 1
- 229940013180 tricaine methanesulfonate Drugs 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 239000007102 tryptic soy broth medium Substances 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
[산업상 이용분야][Industrial use]
본 발명은 동충하초 제제와 생균제 및 동충하초 제제에 생균제를 혼합한 제제 및 이들의 제조방법에 관한 것으로 더욱 상세하게는 어류의 면역력 향상에 의한 항병력 증진으로 양식어류의 폐사를 방지시키고 체중을 증가시키는 동충하초 제제와 여기에 생균제를 혼합한 제제와 동충하초를 단시간에 고농도로 배양하면서 면역 증강물질이 다량 함유되도록 하는 배양공정을 확립하여 양식어 사료첨가제로 이용할 수 있는 동충하초 제제와 동충하초와 생균제를 혼합한 제제 및 그 제조방법에 관한 것이다.The present invention relates to a cordyceps herb preparation, a probiotic and a cordyceps herb preparation containing a probiotic, and a method for preparing the same. And a cultivation process of a cordyceps and a probiotics, which can be used as feed additives for fish farming by establishing a cultivation process containing a mixture of probiotics and cordyceps in a short time at a high concentration and containing a large amount of immune enhancing substances. It relates to a manufacturing method.
[종래기술][Private Technology]
양식어는 고밀도 사육에 의한 폐사율이 대단히 높아 항생제나 백신류를 사용하고 있으나 항생제는 사용이 점차 규제되고 있고 백신류는 투여 및 사용하는데 제한적이어서 어려움이 많다. 따라서 사용하기 편리하고 가격이 저렴하면서 항병력 효과가 뛰어난 제제가 필수적인 상황이다. 사료첨가제 형태의 동충하초 제제 및 동충하초와 생균제의 혼합제제는 어류의 면역력 증강과 생육촉진 및 항병력 강화로 폐사율이 현저히 감소되고 어획량의 증가와 항생제 남용억제에 따른 항생제 수입 절감 및 항생제 내성균의 발현을 방지할 수 있으며 어류 소비자에게도 매우 유익하다.The use of antibiotics or vaccines is high due to the high mortality caused by high-density farming, but antibiotics are increasingly regulated, and vaccines are difficult to administer and use. Therefore, it is necessary to use a formulation that is easy to use and inexpensive and has excellent anti-medical effect. Cordyceps sinensis in the form of feed additives and mixtures of cordyceps and probiotics can significantly reduce mortality due to increased immunity of fish, enhanced growth and anti-history, and reduction of antibiotic imports due to increased catches and antibiotic abuse suppression and prevention of expression of antibiotic resistant bacteria. Can and is very beneficial to fish consumers.
본 발명의 목적은 양식어류에 대해 예방차원의 면역력 증강 제제 개발의 일환으로서 인체에서 면역력 증강, 항암, 항당뇨, 위궤양 예방, 운동능력의 향상 등에 효과가 있는 것으로 보고된 동충하초를 액상배양하여 단기간에 대량 수확함으로써 저렴하게 제제화 하는 것과 어류의 장내에 유익세균총을 형성하게 하는 생균제를 제제화하여 어류에 적용함으로써 면역력 증강에 의한 항병력 강화로 폐사율이 감소되고 생육촉진 및 체중증가 등의 기능을 발휘하는 동충하초 제제와 생균제 및 동충하초와 생균제를 혼합한 제제를 제공하기 위한 것이다.The purpose of the present invention is to develop a liquid immunity enhancement, anti-cancer, anti-diabetic, gastric ulcer prevention, improvement of exercise ability in the human body as part of the development of preventive immune system for enhancing the immune system in aquaculture in a short time Cordyceps sinensis which reduces the mortality rate and promotes growth and weight gain by formulating probiotics that can be formulated inexpensively by mass harvesting and by forming probiotics that form beneficial bacteria in the intestines of fish To provide a formulation with a probiotic and Cordyceps sinensis and a probiotic.
도 1은 본 발명에 따른 제제화 방법의 흐름도1 is a flow chart of a formulation method according to the invention
상기와 같은 본 발명의 목적을 달성하기 위하여 본 발명은 어류의 사료첨가제로 사용되는 동충하초(Paecilomyces japonicus) 배양건조물 제제 MJ100과 기탁번호 제 KCCM-10265로 기탁되어 있는 혼합미생물 MP100 그리고 MJ100과 MP100을 혼합한 제제 MJP100을 제공한다. 이하 본 발명을 더욱 상세히 설명하면 하기와 같다.The present invention to achieve the object of the present invention as described above is mixed with mixture which is Cordyceps (Paecilomyces japonicus) is used as a feed additive for fish culture dry product formulation MJ100 and deposited with Accession No. KCCM-10265 microorganism MP100 and MJ100 and MP100 One formulation MJP100 is provided. Hereinafter, the present invention will be described in more detail.
본 발명은 어류의 면역활성에 의한 항병력 증강 생성용 특수배지를 사용하여 액상배양한 동충하초 균사체 제제 MJ100과 양식어류의 사육환경 특성을 고려하여 저온 숙성 김치에서 분리된 15∼25℃에서 생육 가능한 유익 미생물인 혼합미생물 MP100 및 MJ100과 MP100을 혼합한 MJP100을 개발하였다. 동충하초 사용균주로는 패실로마이세스 자포니쿠스(Paecilomyces japonicus)가 선정되었으며 선정된 균주의 배양조건, 생리적 특성을 바탕으로 면역 증강 효과가 우수한 동충하초를 속성 대량배양하기 위한 배양공정 기술을 확립하기 위한 실험을 수행하였다. 또한 선정된 동충하초의 분류적, 생리화학적 특성에 의해 면역증강 효과가 우수한 선택배지의 조성과 배양조건은 하기 표1과 같다.The present invention is a beneficial microorganism capable of growing at 15-25 ° C. separated from low-temperature ripened kimchi in consideration of the breeding environment of Cordyceps mycelium mycelium preparation MJ100 and cultured fish using liquid-cultured special medium for the development of anti-potentiation by the immune activity of fish. Phosphorus mixed microorganisms MP100 and MJP100 mixed with MJ100 and MP100 were developed. Paecilomyces japonicus was selected as the fungus of Cordyceps sinensis, and it was established to establish a culture process technology for rapid mass cultivation of Cordyceps with excellent immunity-improving effect based on the culture conditions and physiological characteristics of the selected strains. The experiment was performed. In addition, the composition and culture conditions of the selective medium excellent immunity enhancing effect by the classification, physiological and chemical properties of the selected Cordyceps sinensis are shown in Table 1 below.
동충하초 균주를 6ℓ발효조(NBS)에서 면역증강용 생산배지를 사용하여 배양후 배양액 1ℓ당 전분 2Kg을 혼합하여 균질화 시킨 다음 50∼60℃에서 24시간 건조하였다. 건조된 배양건조물을 분쇄하여 분발화 시킨 다음 어류에 섭취시킨 후 면역능을 조사하였다. MJ100의 어류에 대한 면력능 측정은 MJ100을 넙치 치어에 4주간사료에 첨가하여 투여한 후 MS222(tricaine methanesulfonate)로 마취시킨 넙치로부터 두신을 무균적으로 분리한 후 4℃로 냉장한 Hank's balanced salt solution(HBSS)에 넣어 가는 망사를 이용하여 세포들을 분리해 낸다. 분리된 두신세포는 다시 34/51%의 percoll density gradient를 이용하여 4℃에서 400×g로 30분간 원심분리한 다음 34%와 51% 사이의 세포층을 가는 파스퇴르 피펫을 이용하여 분리하였다. 최종적으로 분리된 세포는 HBSS로 400×g에서 5분간 2번 세척하였다. 세포의 생존유무는 trypan blue stain을 이용하여 분석하였으며 실험에 사용한 식세포의 세포수는 1×106cells/ml HBSS로 조절하였다. 식세포에서 방출되는 reactive oxygen intermediates(ROIs)는 chemiluminescent(CL) response 분석으로 automatic photoluminometer(Bio-orbit 1251, Finland)를 사용하여 측정하였다. 즉, 각 test cuvette은 luminol 0.7ml와 세포 분산액 0.4ml를 혼합하여 5분간 실온에서 incubation한 후 측정직전에 opsonized zymosan 0.3ml를 첨가하여 100분간 측정하였다. MJ100을 사료에 0.1%, 0.3%, 0.5%를 첨가하여 4주간 투여 후 각 실험군의 넙치를 무작위로 채취하여 두신 식세포를 분리한 후 CL반응을 측정한 결과 MJ100의 첨가농도가 높아짐에 따라 대조군에 비해 점차 높은 CL값을 나타냈으며 0.5% 첨가시 대조군에 비해 2배 이상의 면역능이 증진되었음을 그림 1에 나타내었다.Cordyceps sinensis strains were homogenized by mixing 2Kg of starch per 1L of culture after incubation using a production medium for immuno-enhancement in a 6L fermentation tank (NBS) and then dried at 50 to 60 ° C for 24 hours. The dried culture dry matter was pulverized and ingested in fish, and then examined for immunity. The strength of MJ100 in fish was measured by adding MJ100 to the flounder fry for 4 weeks, and after aseptic isolation of ducin from the flounder annealed with MS222 (tricaine methanesulfonate), Hank's balanced salt solution refrigerated at 4 ℃ Isolate the cells using a mesh that goes into (HBSS). The isolated scalp cells were centrifuged at 400 × g for 30 minutes at 4 ° C. using a 34/51% percoll density gradient, and then separated between 34% and 51% cell layers using a thin Pasteur pipette. Finally, the isolated cells were washed twice with HBSS at 400 × g for 5 minutes. The viability of the cells was analyzed using trypan blue stain, and the cell number of the phagocytes used in the experiment was controlled by 1 × 10 6 cells / ml HBSS. Reactive oxygen intermediates (ROIs) released from phagocytes were measured using an automatic photoluminometer (Bio-orbit 1251, Finland) for chemiluminescent (CL) response analysis. That is, each test cuvette was mixed with 0.7 ml of luminol and 0.4 ml of cell dispersion and incubated at room temperature for 5 minutes, and then measured for 100 minutes by adding 0.3 ml of opsonized zymosan immediately before measurement. MJ100 was added 0.1%, 0.3%, and 0.5% to the feed for 4 weeks, and then the flounders of each experimental group were randomly taken to isolate the phagocytes. After the CL response was measured, the concentration of MJ100 was increased. The CL value was gradually increased, and when 0.5% was added, it showed more than twice the immunity compared to the control.
그림 1. MJ100의 농도별 첨가에 따른 넙치 두신 식세포의 CL반응 효과 또한 MJP100을 사료에 0.1%, 0.3%, 0.5%를 첨가하여 4주간 투여 후 각 실험군의 넙치를 무작위로 채취하여 두신 식세포를 분리한 후 CL반응을 측정한 결과 대조군에 비하여 0.3%첨가시 2배, 0.5%첨가시 3배의 면역능이 향상 되었음을 그림 2에 나타내었다.Fig. 1. CL response effect of flounder head phagocytes with different concentrations of MJ100. In addition, 0.1%, 0.3%, and 0.5% of MJP100 was added to the feed for 4 weeks. As a result of measuring the CL response, it was shown in Figure 2 that the immune activity was improved by 2 times at 0.3% and 3 times at 0.5% when compared to the control group.
그림 2. MJP100의 농도별 첨가에 따른 넙치 두신 식세포의 CL반응효과Figure 2. CL response effect of flounder head phagocytes with different concentrations of MJP100
( a ; MJ100 0.1%+ MP100 0.1%, b ; MJ100 0.3%+ MP100 0.3%, c ; MJ100 0.5%+ MP100 0.5% )(a; MJ100 0.1% + MP100 0.1%, b; MJ100 0.3% + MP100 0.3%, c; MJ100 0.5% + MP100 0.5%)
MP100과 해수어 병원세균의 혼합배양에 의한 해수어 병원세균의 생육저해 작용을 조사하기 위하여 MP100은 4종의 균이 각각 g당 108의 생균수를 함유한 접종시료를 만들고 병원균중 에드워드시엘라 타다(Edwardsiellar tarda)균은 트립톤과 대두분이 함유된 액상배지(Tryptic soy broth),슈도모나스 풀루리센스(Pseudomonas fluorescens) 및 비브리오 콜레라(Vibrio cholerae)균은 NaCl이 2.5%함유된 젖당 부이온(Lactose broth)배지를 사용하여 25℃에서 24시간 배양 후 106cells/ml의 생균수가 되도록 생리식염수로 단계 희석하여 접종 시료액을 만든 다음 MP100과 함께에드워드시엘라 타다균은 tryptic soy broth배지, 슈도모나스 풀루리센스 및 비브리오 콜레라균은 NaCl이 2.5%함유된 젖당 부이온(Lactose broth)배지 각각 1%씩 접종하여 25℃에서 배양하였다. 각각의 혼합배양액을 6시간 간격으로 채취하여 멸균 생리 식염수로 희석한 후 생균수를 측정하였다. 에드워드시엘라 타다균과 MP100 함유균의 생균수 측정은 tryptic soy agar 배지와 MRS 배지에 도말하여 25℃에서 24시간 배양 후 각각의 균에 대한 생균수를 측정하였으여, 슈도모나스 풀루리센스 및 비브리오 콜레라균은 NaCl이 2.5% 함유된 LB 평판배지와 브로모크레졸 퍼플(BCP) 배지에 각각 도말하여 25℃에서 24시간 배양후 병원균과 MP100 함유균의 생균수를 측정하였다. MP100의 비브리오 콜레라균에 대한 증식 저해능 및 항균력을 측정하기 위하여 25℃에서 NaCl 2.5%가 함유된 LB 배지를 사용하여 비브리오 콜레라균 단독 및 MP100과 48시간 혼합 배양한 결과 그림 3에서 보는 바와 같이 비브리오 콜레라균을 단독배양한 경우에는 정상적인 성장을 하였으나 혼합 배양의 경우 접종 후 12시간 이후부터 균수가 감소하기 시작하여 30시간 후에는 비브리오 콜레라균의 증식을 완전히 저해하였다.In order to investigate the inhibition of growth of marine fish pathogens by mixing cultures of MP100 and marine fish pathogens, MP100 produced four inoculated samples containing 10 8 cells per gram of bacteria, and Edward Siella spp. Edwardsiellar tarda are Tryptic soy broth, Pseudomonas fluorescens and Vibrio cholerae containing tryptone and soy flour, and lactose broth containing 2.5% NaCl. After incubation at 25 ° C. for 24 hours using a medium, the solution was inoculated with physiological saline to give 10 6 cells / ml of viable cells. And Vibrio cholera bacteria were inoculated with 1% each of lactose broth medium containing 2.5% NaCl and incubated at 25 ° C. Each mixed culture solution was taken at 6 hour intervals, diluted with sterile saline, and the number of viable cells was measured. The viable cell counts of Edward Siela tada and MP100-containing bacteria were plated on tryptic soy agar medium and MRS medium and incubated at 25 ° C. for 24 hours, and the viable cell counts of each bacterium were measured. Silver NaCl was plated on 2.5% LB plate medium and bromocresol purple (BCP) medium, respectively, and cultured at 25 ° C. for 24 hours, and the viable cell counts of pathogens and MP100-containing bacteria were measured. In order to measure the growth inhibition and antimicrobial activity of MP100 against Vibrio cholera, Vibrio cholera was mixed with Vibrio cholera alone and MP100 for 48 hours using LB medium containing 2.5% NaCl at 25 ° C. In the case of culture alone, the growth was normal, but in the mixed culture, the number of bacteria started to decrease after 12 hours after inoculation, and completely inhibited the growth of Vibrio cholera bacteria after 30 hours.
그림 3. MP100에 의한 비브리오 콜레라균의 생육 저해효과Figure 3.Inhibitory Effect of Vibrio Cholera by MP100
● ; 비브리오 콜레라 단독배양에 의한 비브리오 콜레라균의 생균수●; Viable Cell Count of Vibrio Cholera by Vibrio Cholera Culture
■ ; MP100과 혼합 배양시 MP100함유 균주의 생균수■; Number of viable cells of MP100-containing strains when mixed with MP100
▲ ; MP100과 혼합 배양시 비브리오 콜레라균의 생균수▲; Viable Cell Number of Vibrio Cholera in Mixed Culture with MP100
MP100의 에드워드시엘라 타다균에 대한 증식 저해능 및 항균력을 측정하기 위하여 25℃에서 tryptic soy broth 배지를 사용하여 에드워드시엘라 타다균 단독 및 MP100과 48시간 혼합 배양한 결과 그림 4에서 보는 바와 같이 에드워드시엘라 타다균을 단독배양한 경우에는 정상적인 성장을 하였으나 혼합 배양의 경우 접종 후 12시간 이후부터 균수가 감소하기 시작하여 24시간 후에는 에드워드시엘라 타다균의 증식을 완전히 저해하였다.In order to measure the proliferation inhibitory and antimicrobial activity of Edwards siella tada against MP100, the result of cultivation of Edwards siella tada alone and MP100 for 48 hours using tryptic soy broth medium at 25 ° C was shown in Figure 4. In the case of cultivation of ella tada alone, normal growth was observed, but in the case of mixed culture, the number of bacteria started to decrease after 12 hours after inoculation and completely inhibited the growth of Edwardsella elda bacteria after 24 hours.
그림 4. MP100에 의한 에드워드시엘라 타다균의 생육 저해효과Figure 4. Growth Inhibition Effect of Edward Siella Tadida by MP100
● ; 에드워드시엘라 타다 단독배양에 의한 에드워드시엘라 타다균의 생균수●; The number of viable bacteria of Edward ciella tada by cultivation of Edward ciella tada alone
■ ; MP100과 혼합 배양시 MP100함유 균주의 생균수■; Number of viable cells of MP100-containing strains when mixed with MP100
▲ ; MP100과 혼합 배양시 에드위드시엘라 타다균의 생균수▲; The viable cell count of Ed with Siela tada in culture with MP100
MP100의 슈도모나스 풀루리센스균에 대한 증식 저해능 및 항균력을 측정하기 위하여 25℃에서 젖당부이온배지(LB배지)를 사용하여 슈도모나스 풀루리센스 단독 및 MP100과 48시간 혼합 배양한 결과 그림 5에서 보는 바와 같이 슈도모나스 풀루리센스균을 단독배양한 경우에는 정상적인 성장을 하였으나 혼합 배양의 경우 접종 후 12시간 이후부터 균수가 감소하기 시작하여 18시간 후에는 슈도모나스 풀루리센스균의 증식을 완전히 저해하였다.In order to determine the growth inhibition and antimicrobial activity of Pseudomonas pullulicense bacteria of MP100 using Pseudomonas pullulicesen alone and MP100 incubated for 48 hours with Lactobacillus ion medium (LB medium) at 25 ℃ as shown in Figure 5 Likewise, when Pseudomonas pullulicense bacteria were cultured alone, normal growth was observed, but in the case of mixed culture, the number of bacteria started to decrease after 12 hours after inoculation and completely inhibited the growth of Pseudomonas pullulicense bacteria after 18 hours.
그림 5. MP100에 의한 슈도모나스 플루리센스균의 생육 저해효과Figure 5.Inhibitory Effect of Pseudomonas Fluriscens Growth by MP100
● ; 슈도모나스 플루리센스 단독배양에 의한 슈도모나스 플루리센스균의 생균수●; Viable Counts of Pseudomonas Flurisense Bacteria by Pseudomonas Flurisense Monoculture
■ ; MP100과 혼합 배양시 MP100함유 균주의 생균수■; Number of viable cells of MP100-containing strains when mixed with MP100
▲ ; MP100과 혼합 배양시 슈도모나스 플루리센스균의 생균수▲; Viable Counts of Pseudomonas Fluriscens in Mixed Culture with MP100
[실시예]EXAMPLE
본 발명은 바람직한 실시예 및 비교예를 기재한다. 그러나 하기한 실시예는 본 발명의 구성 및 효과를 나타내는 본 발명의 일 실시예 일 뿐 본 발명이 하기한 실시예에 한정되는 것은 아니다. 본 발명에 따른 MJ100과 MP100 및 MJP100을 넙치 치어에 투여하는 실험을 수행하였고 어체의 증체율과 치사율을 조사하였다. 양식실험은 수온 20℃를 유지시킨 실험수조에서 넙치 치어 720마리를 30마리씩 무작위로 나누어 24개의 수조에 배치하여 2주간 순치 후 MJ100, MP100 및 MJP100을 사료에 0.1%, 0.3%, 0.5%, 1.0% 함유시켜 투여 하였으며 대조군은 순수 사료만 투여하였다. 각각의 실험군은 2반복구로 하였으며 4주간 실험사료를 투여 후 증체율과 치사율을 분석하였다. 어체량은 각 실험군에서 임의로 10마리를 채취하여 측정하였으며 이러한 방법을 2회 반복하여 어체의 평균 증체량을 계산하였다. 폐사율 측정은 1톤 수조에 각 실험군별로 망으로 격리한 후 해수어 병원성 세균인 에드워드시엘라 타다(Edwardsiella tarda)를 해수 리터(L)당 3.4×107의 균수로 분산시켜 자연적인 감염경로와 같은 환경을 조성한 후 각 실험군별 누적폐사율을 조사하였다.The present invention describes preferred examples and comparative examples. However, the following examples are merely examples of the present invention showing the constitution and effects of the present invention, and the present invention is not limited to the following examples. MJ100 and MP100 and MJP100 according to the present invention was administered to the flounder fry and the weight gain and mortality of the fish were investigated. In aquaculture experiments, 720 flounder fry flounders were randomly divided into 30 tanks and placed in 24 tanks for 2 weeks. MJ100, MP100 and MJP100 were added 0.1%, 0.3%, 0.5%, 1.0 % Was administered and the control group was administered only pure feed. Each experimental group was subjected to two relapses and analyzed for gain and mortality after administration of the experimental feed for 4 weeks. Fish body weight was determined by randomly taking 10 animals from each experimental group, and the average weight gain of the fish was calculated by repeating this method twice. The mortality was measured in a one-ton tank with each network, and the seaborne fish pathogenic bacteria Edwardsiella tarda was dispersed at 3.4 × 10 7 bacteria per liter (L) of seawater. After the composition, the cumulative mortality of each experimental group was investigated.
MJ100를 사료에 첨가하여 4주간 넙치 치어에 투여한 후의 증체량은 대조군에 비해 MJ100을 0.5%와 1.0% 첨가한 군에서 각각 28% 및 17% 높은 증가율을 보여 0.5%의 첨가가 가장 효과적인 것으로 관찰되었으며 이를 표 2에 나타내었다.The weight gain after MJ100 was added to feed for 4 weeks in flounder fry was 28% and 17% higher in MJ100 and 0.5% and 1.0% than control, respectively. This is shown in Table 2.
MP100를 사료에 첨가하여 4주간 넙치 치어에 투여한 후의 증체량은 대조군에비해 MP100을 0.3%와 0.5% 첨가한 군에서 대조군에 비해 각각 4% 및18%의 증체율을 보여 0.5%의 첨가가 가장 효과적인 것으로 관찰되었으며 이를 표 3에 나타내었다.The weight gain after MP100 was added to feed for 4 weeks in flounder fry was 4% and 18% increase compared to the control in the group that added 0.3% and 0.5% MP100, respectively. Was observed and is shown in Table 3.
또한, MJP100을 0.1%, 0.3%, 0.5%로 사료에 첨가하여 2주간 투여한 후의 증체율은 대조군에 비해 각각 1.6배, 2.9배, 2.1배로 높은 증체 효과를 보여 0.3%의 첨가가 가장 효과적인 것으로 관찰되었으며 이를 표 4에 나타내었다.In addition, the increase rate of MJP100 at 0.1%, 0.3%, and 0.5% was increased to 1.6, 2.9, and 2.1 times, respectively, compared to the control group. This is shown in Table 4.
해수 병원균인 에드워드시엘라 타다를 수조에 분산시킨 후 사료투여를 중지한 상태에서 MP100 투여군에 대한 항병력을 조사한 결과 대조군은 해수 병원균을 투여 후 7일 동안의 누적 폐사율이 80%인 반면 MP100 0.3% 투여군은 40%, 0.5% 투여군은 30%, 1.0% 투여군은 57%의 폐사율을 보여 MP100 0.5%를 사료에 첨가한 것이 가장 우수한 항병력을 보이는 것으로 나타났으며 이를 표 5에 나타내었다.After dispersing the seaweed pathogen Edward Siela tada in the tank and stopping the feeding, the control group examined the anti-histopathy against the MP100 group, and the control group had 80% cumulative mortality rate for 7 days after the seawater pathogen was administered, whereas the MP100 0.3% group The 40%, 0.5% treated group showed 30% and 1.0% treated group showed a mortality rate of 57%, and it was shown that adding 0.5% MP100 to the feed showed the best anti-morbidity.
또한, MJP100를 투여한 경우 대조군은 해수 병원균을 투여 후 사료급여를 중지한 상태에서 7일 동안의 누적 폐사율이 80%인 반면 MJP100을 0.1%, 0.3%, 0.5%를 투여한 결과 누적 폐사율은 각각 35%, 10%, 20%로 MJP100을 0.3% 투여한 군이 대조군에 비해 8배 이상의 매우 높은 생존율을 보였으며 이를 표 6에 나타내었다.In addition, when MJP100 was administered, the control group had 80% cumulative mortality rate for 7 days after stopping the feeding of seawater pathogens, whereas 0.1%, 0.3%, 0.5% of MJP100 was administered. The group administered with 0.3% MJP100 at 35%, 10%, and 20% showed a very high survival rate of 8 times or more compared to the control group, which is shown in Table 6.
본 발명의 동충하초 제제와 4종의 균을 함유한 생균제 및 동충하초 제제와 생균제를 혼합한 제제는 어류의 면역능을 향상시키고 항병력 증진과 생육촉진으로 폐사율 감소와 어획량 증가 및 항생제 대체용으로 효용성이 높다.Cordyceps herb preparations of the present invention and probiotics containing four fungi and preparations mixed with cordyceps herb preparations and probiotics improve the immunity of fish and increase the morbidity, increase catches, and increase the yield by increasing the viability and promoting growth.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0026279A KR100483911B1 (en) | 2001-05-14 | 2001-05-14 | Feed Additive Composition for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0026279A KR100483911B1 (en) | 2001-05-14 | 2001-05-14 | Feed Additive Composition for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020087591A true KR20020087591A (en) | 2002-11-23 |
KR100483911B1 KR100483911B1 (en) | 2005-04-18 |
Family
ID=27704864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0026279A KR100483911B1 (en) | 2001-05-14 | 2001-05-14 | Feed Additive Composition for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100483911B1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57130917A (en) * | 1981-02-06 | 1982-08-13 | Tanabe Seiyaku Co Ltd | Antimicrobial agent for fish |
JPH0691797B2 (en) * | 1985-12-10 | 1994-11-16 | 旭化成工業株式会社 | Feed additives for aquaculture |
JP2583473B2 (en) * | 1993-02-15 | 1997-02-19 | 株式会社松本微生物研究所 | Remedies for vibrio infectious disease and treatment and prevention using the same |
KR20000052237A (en) * | 1999-01-30 | 2000-08-16 | 장세국 | A method of manufacturing a feed composite ,which contains yellow earth and chitosan, for livestock and cultured fish |
CN100473284C (en) * | 1999-03-26 | 2009-04-01 | 杣源一郎 | Additives for crustacean or fish feeds and feeds |
KR100347216B1 (en) * | 2000-10-19 | 2002-08-03 | 김중배 | Feed additive containing Pacilomyces japonica or Cordyceps militaris and its manufacturing method |
-
2001
- 2001-05-14 KR KR10-2001-0026279A patent/KR100483911B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR100483911B1 (en) | 2005-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106957810B (en) | Pediococcus acidilactici and application thereof | |
CN109749957B (en) | Preparation and application of lactobacillus gasseri preparation with aquatic pathogenic bacteria antagonistic property | |
CN102293340B (en) | Compound premix able to improve immune function for pigs | |
CN105062933A (en) | Lactobacillus reuteri and application thereof | |
CN101671638A (en) | New strain of bifidobacterium and fermentative preparation method and application thereof | |
CN102965316B (en) | Bacteriocin containing class and the feed addictive of Pediococcus acidilactici, premix and batch | |
CN113040390B (en) | Probiotic salt-tolerant lactobacillus johnsonii and application thereof in preventing and treating pathogenic bacteria in livestock and poultry aquiculture | |
CN114085789B (en) | Pediococcus pentosaceus MA.WTPQJ01 and application thereof | |
CN108085265B (en) | Bacillus coagulans new strain, and microecological preparation and feed thereof | |
CN108660097B (en) | Screening and application of fish-source enterococcus faecium R8 | |
CN102165995B (en) | Composite premix for pig | |
KR20090040026A (en) | Novel leuconostoc mesenteroide from kimchi with inhibiting activities on pathogenic microorganism and use thereof | |
US11033032B2 (en) | Leclercia adecarboxylata biocontrol strain efficiently inhibiting production of aflatoxins by Aspergillus flavus and application thereof | |
CN113088468B (en) | Lactobacillus casei Ma. GLRGJ1 and application thereof | |
CN104726359B (en) | One bacillus pumilus BP and application thereof | |
KR100371503B1 (en) | Probiotic preparations for aquacultured fish and its production method | |
CN109897800A (en) | The strong enterococcus A8-1 of one plant of selenium-rich and its application | |
CN114015626A (en) | Lactobacillus plantarum-like bacteria with bacteriostatic function, composite preparation thereof and application | |
CN108690820B (en) | High ampicillin resistance lactobacillus plantarum and breeding method and application thereof | |
KR20020087591A (en) | Preparation and its production method for immunopotentiating, antibacterial activity and growth promotion of aquacultured fish | |
CN106689798B (en) | Marine synbiotic additive, preparation method thereof and application thereof in stichopus japonicus culture | |
KR20160026263A (en) | Feed for farming-fish and Farming-fish farmed using that | |
CN114836338B (en) | Lactobacillus rhamnosus A5 and application thereof | |
CN107418924A (en) | A kind of preparation method and applications of polar region beneficial bacteria member | |
CN114521608B (en) | Fermentation synergistic composition of lactic acid bacteria and bacillus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130311 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150223 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180402 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190401 Year of fee payment: 15 |